University of Alabama Medicine 2020 ASCO Highlights

 

University of Alabama Medicine 2020 ASCO Highlights
Avatar

2020 ASCO Update on Azacitidine Combinations in Frontline AML: Does the Addition of Venetoclax Lead to Improved Response in Patients Ineligible for Intensive Therapy?

By University of Alabama Medicine 2020 ASCO Highlights FEATURING Pankit Vachhani
By University of Alabama Medicine 2020 ASCO Highlights FEATURING Pankit Vachhani
135 views
September 9, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

19:22
Janssen Oncology

Doc Talk Podcast

Feat. J. Hamilton, M. Fabrizio, M. Taha

Featured Video

21:17
Janssen Oncology

The Man Cave

Feat. J. Hamilton, M. Fabrizio, M. Taha
Videos
16:36
University of Alabama Medicine 2020 ASCO Highlights

UAB ASCO 2020 Updates on HIF Inhibitors in Advanced RCC: Does Belzut…

Feat. A. Basu
13:07
University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Highlights on Newly Diagnosed MM: KRd vs. VRd - Are There …

Feat. S. Bal
05:17
University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Highlights on Advanced NSCLC: What Is the Clinical Benefit…

Feat. D. Das
06:56
University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on EGFR+ mNSCLC: Should We Incorporate Osimertinib …

Feat. D. Das
13:57
University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO IMvigor 130 Bladder Cancer Updated Results: Does the Addit…

Feat. L. Nandagopal
09:38
University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on Advanced RCC: Are We Over-Treating Patients With…

Feat. L. Nandagopal
07:32
University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on Prostate Cancer: How Effective Is Enzalutamide i…

Feat. L. Nandagopal
15:11
University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on CP-CML: What Dose of Ponatinib Is Both Safe and …

Feat. P. Vachhani
10:41
University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on R/R AML: What AMG 330 Dosage Is Safe and Tolerab…

Feat. P. Vachhani
08:27
University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on Azacitidine Combinations in Frontline AML: Does …

Feat. P. Vachhani
07:10
University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on Azacitidine Combinations in AML: Are Aza/Ven/Ivo…

Feat. P. Vachhani
08:08
University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on Azacitidine Combinations in Frontline AML: What …

Feat. P. Vachhani
13:15
University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on Azacitidine Combinations in Myeloid Malignancies…

Feat. P. Vachhani
12:24
University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on mBC: Do Surgery and Radiation After Initial Syst…

Feat. E. Stringer-Reasor
11:17
University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on PIK3CA HR+ BC: Is Alpelisib Effective After CDK4…

Feat. E. Stringer-Reasor
14:19
University of Alabama Medicine 2020 ASCO Highlights

2020 ASCO Update on CAR-T in Lymphoma: First CD19/22 Dual Targeting …

Feat. A. Mehta